Application of the Yamanaka Transcription Factors <i>Oct4</i>, <i>Sox2</i>, <i>Klf4</i>, and <i>c-Myc</i> from the Laboratory to the Clinic

Application of the Yamanaka Transcription Factors <i>Oct4</i>, <i>Sox2</i>, <i>Klf4</i>, and <i>c-Myc</i> from the Laboratory to the Clinic

The transcription factors <i>Oct4</i>, <i>Sox2</i>, <i>Klf4</i>, and <i>c-Myc</i> enable the reprogramming of somatic cells into induced pluripotent cells. Reprogramming generates newly differentiated cells for potential therapies in cancer, neurodegen...

Full description

Bibliographic Details
Main Authors: Marisol Aguirre, Manuela Escobar, Sebastián Forero Amézquita, David Cubillos, Camilo Rincón, Paula Vanegas, María Paula Tarazona, Sofía Atuesta Escobar, Juan Camilo Blanco, Luis Gustavo Celis
Format: Article
Language:English
Published: MDPI AG 2023-08-01
Series:Genes
Subjects:
cell- and tissue-based therapy
<i>Oct4</i>
<i>Sox2</i>
<i>Klf4</i>
<i>c-Myc</i>
cancer
Online Access:https://www.mdpi.com/2073-4425/14/9/1697

Internet

https://www.mdpi.com/2073-4425/14/9/1697

Similar Items